Peroxisome proliferator-activated receptor-g agonist treatment increases septation and angiogenesis and decreases airway hyperresponsiveness in a model of experimental neonatal chronic lung disease.

Takeda K, Okamoto M, de Langhe S, Dill E, Armstrong M, Reisdorf N, Irwin D, Koster M, Wilder J, Stenmark KR, West J, Klemm D, Gelfand EW, Nozik-Grayck E, Majka SM
Anat Rec (Hoboken). 2009 292 (7): 1045-61

PMID: 19484746 · PMCID: PMC2873208 · DOI:10.1002/ar.20921

MeSH Terms (22)

Animals Animals, Newborn Bronchoconstriction Cell Differentiation Disease Models, Animal Fibroblasts Humans Hyperoxia Infant, Newborn Infant, Newborn, Diseases Lung Lung Diseases Mice Mice, Inbred C57BL Muscle, Smooth Neovascularization, Physiologic PPAR gamma Respiratory System Rosiglitazone Thiazolidinediones Treatment Outcome Vasodilator Agents

Connections (1)

This publication is referenced by other Labnodes entities: